蛋白质稳定维持T细胞分化潜力和瘤透淋巴细胞功能
bioRxiv : the preprint server for biology
|February 23, 2026
概括
瘤透淋巴细胞 (TIL) 可能会耗尽,阻碍抗瘤免疫力. 在临床前模型中,通过重新引入E3泛素酶来恢复蛋白质稳定,改善了TIL功能并增强了癌症免疫治疗结果.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 蛋白质稳定性 蛋白质稳定性
背景情况:
- 瘤透淋巴细胞 (TIL) 经常表现出枯竭的表型,限制了它们的抗瘤疗效.
- 组织内存T细胞 (TRM) 提供长期保护,并且在瘤中存在时与更好的患者预后有关.
研究的目的:
- 研究蛋白质稳定在T细胞功能和分化中的作用.
- 为了确定底层TIL耗尽和TRM维护的分子机制.
- 通过向蛋白质稳定,探索改善抗瘤免疫力的治疗策略.
主要方法:
- 对T细胞种群的蛋白质组和转录组分析.
- 在TIL和TRM中分析E3泛基因酶表达 (NEURL3,RNF149,WSB1).
- 功能性测试评估TIL抗瘤活性和T细胞分化.
- 癌症免疫治疗的临床前模型.
主要成果:
- 在TIL中失去特定的E3泛素酶 (NEURL3,RNF149,WSB1) 与蛋白质稳定缺陷和蛋白质展开有关.
- 这些酶的强制表达保留了类似茎的TIL群体,并增强了抗瘤功能.
- 联酶淘汰会损害TIL功能,并在感染期间改变T细胞分化.
- 恢复酶表达改善了临床前癌症模型中的免疫治疗结果.
结论:
- 蛋白质稳定,由E3泛素酶调节,对于维持TIL功能和防止疲劳至关重要.
- 向蛋白质稳定路径为增强癌症免疫治疗提供了一个有希望的策略.
- 恢复E3酶表达可以挽救TIL功能并改善抗瘤反应.
相关概念视频
T Cell Activation and Clonal Selection
16.5K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
16.5K
T Cell Types and Functions
2.8K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.8K
Abnormal Proliferation
5.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Cancer Stem Cells and Tumor Maintenance
6.1K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.1K
Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
B Cell Activation and Differentiation
17.2K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
17.2K


